ELAPRASE SOLUTION FOR INTRAVENOUS INFUSION

Manufacturer
GENZYME CORPORATION(UNITED STATES)

Registraction Number
MAL20091972ACZ


Content:

• Active Ingredient: Idursulfase
• Excipients: Various inactive ingredients to stabilize the solution

• Mucopolysaccharidosis Type II (Hunter Syndrome): Used to treat the non-neurological symptoms of MPS II in patients with the iduronate-2-sulfatase (I2S) enzyme deficiency.

1. Dosage and Administration: The dosage and administration should be determined by a healthcare provider based on the patient's weight and medical condition. It is typically administered via intravenous infusion.
2. Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
3. Handling: Use aseptic techniques to avoid contamination. Dispose of syringes and needles safely after use.
4. Monitoring: Regular monitoring of the patient's condition and any potential side effects as advised by the healthcare provider.